Artículos por temáticas

A novel SCARB2 mutation causing late-onset progressive myoclonus epilepsy.

Higashiyama Y, Doi H, Wakabayashi M, Tsurusaki Y, Miyake N, Saitsu H, Ohba C, Fukai R, Miyatake S, Joki H, Koyano S, Suzuki Y, Tanaka F, Kuroiwa Y, Matsumoto N.

Mov Disord. 2013 Apr;28(4):552-3. doi: 10.1002/mds.25296. No abstract available.

Progressive encephalomyelitis with rigidity and myoclonus: a syndrome with diverse clinical features and antibody responses.

Shugaiv E, Leite MI, Şehitoğlu E, Woodhall M, Çavuş F, Waters P, İçöz S, Birişik Ö, Uğurel E, Ulusoy C, Kürtüncü M, Vural B, Vincent A, Akman-Demir G, Tüzün E.

Eur Neurol. 2013;69(5):257-62. doi: 10.1159/000342237.

[Role of target controlled infusion of remifentanil for the prevention of etomidate induced myoclonus during general anesthesia].

Zou L, Yuan H, Wang HY, Geng ZY, Xu L, Sun L.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Feb;35(1):112-5. Chinese.

A 29-year-old female with progressive myoclonus and cognitive decline.

Taylor D, Haynes HR, Graham A, Gerhand S, Kurian KM.

Case Rep Neurol Med. 2013;2013:125672. doi: 10.1155/2013/125672.

White matter degeneration with Unverricht-Lundborg progressive myoclonus epilepsy: a translational diffusion-tensor imaging study in patients and cystatin B-deficient mice.

Manninen O, Koskenkorva P, Lehtimäki KK, Hyppönen J, Könönen M, Laitinen T, Kalimo H, Kopra O, Kälviäinen R, Gröhn O, Lehesjoki AE, Vanninen R.

Radiology. 2013 Oct;269(1):232-9. doi: 10.1148/radiol.13122458.

Clinical characteristics and therapeutic response of objective tinnitus due to middle ear myoclonus: a large case series.

Park SN, Bae SC, Lee GH, Song JN, Park KH, Jeon EJ, Park YS, Yeo SW.

Laryngoscope. 2013 Oct;123(10):2516-20. doi: 10.1002/lary.23854.

Atypical antipsychotic olanzapine reversed deficit on prepulse inhibition of the acoustic startle reflex produced by microinjection of dizocilpine (MK-801) into the inferior colliculus in rats.

Zangrando J, Carvalheira R, Labbate G, Medeiros P, Longo BM, Melo-Thomas L, Silva RC.

Behav Brain Res. 2013 Nov 15;257:77-82. doi: 10.1016/j.bbr.2013.09.018.

Mucolipidosis and progressive myoclonus epilepsy: a distinctive phenotype.

Menon RN, Jagtap S, Thakkar R, Narayanappa G, Nair M.

Neurol India. 2013 Sep-Oct;61(5):537-9. doi: 10.4103/0028-3886.121943. No abstract available.

PAC1 receptor (ADCYAP1R1) genotype is associated with dark-enhanced startle in children.

Jovanovic T, Norrholm SD, Davis J, Mercer KB, Almli L, Nelson A, Cross D, Smith A, Ressler KJ, Bradley B.

Mol Psychiatry. 2013 Jul;18(7):742-3. doi: 10.1038/mp.2012.98. No abstract available.

A unique case of peripheral myoclonus.

Ross Russell AL, Knight W, Oware A, Fuller GN.

J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):117-8. doi: 10.1136/jnnp-2012-303795. No abstract available.

Is startle a lateralised response in early infancy?

Franchin L, Agnoli S, Dondi M.

Laterality. 2013;18(4):460-75. doi: 10.1080/1357650X.2012.704038.

Prepulse inhibition predicts working memory performance whilst startle habituation predicts spatial reference memory retention in C57BL/6 mice.

Singer P, Hauser J, Llano Lopez L, Peleg-Raibstein D, Feldon J, Gargiulo PA, Yee BK.

Behav Brain Res. 2013 Apr 1;242:166-77. doi: 10.1016/j.bbr.2012.12.011.

Risk for eating disorders modulates startle-responses to body words.

Herbert C, Kübler A, Vögele C.

PLoS One. 2013;8(1):e53667. doi: 10.1371/journal.pone.0053667.

Transitory stapedial myoclonus in a patient with benign fasciculation syndrome.

Brigo F, Storti M, Lochner P, Nardone R.

J Laryngol Otol. 2013 Jun;127(6):605-6. doi: 10.1017/S0022215113000297. Review.

Lead exposure and fear-potentiated startle in the VA Normative Aging Study: a pilot study of a novel physiological approach to investigating neurotoxicant effects.

Grashow R, Miller MW, McKinney A, Nie LH, Sparrow D, Hu H, Weisskopf MG.

Neurotoxicol Teratol. 2013 Jul-Aug;38:21-8. doi: 10.1016/j.ntt.2013.04.003.